J. Lim

Characteristics, behaviour and role of biomarkers in metastatic triple-negative breast cancer

P. Tan, H. Sasano, J. Yeong, 2019, Journal of Clinical Pathology.

Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice

P. Tan, J. Yeong, J. Iqbal, 2021, Cancers.

Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer

P. Tan, Bernett Lee, J. Yeong, 2022, Breast Cancer Research.

Soft Tissue Leiomyosarcoma With Microsatellite Instability, High Tumor Mutational Burden, and Programmed Death Ligand-1 Expression Showing Pathologic Complete Response to Pembrolizumab: A Case Report

J. Yeong, J. Chan, E. Chen, 2022, JCO precision oncology.

Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC

Yong Cheng Poh, Zi Long Chow, P. Tan, 2020, Journal of Clinical Pathology.

A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers—Analytical validation and performance evaluation with clinical samples

P. Tan, B. Teh, M. Tan, 2022, Frontiers in Molecular Biosciences.